McDermott Will & Emery represented Trio Petroleum Corp. in the offering. Trio Petroleum Corp., an oil and gas exploration and development company focused on strategic, high-growth...
Trio Petroleum Corp’s $6 Million Initial Public Offering
Pasithea Therapeutics’ Acquisition of AlloMek Therapeutics
McDermott Will & Emery represented Pasithea Therapeutics Corp. in the transaction. Pasithea Therapeutics Corp., a biotechnology company focused on the discovery, research and development of innovative...
Mullen Automotive’s $148.2 Million Acquisition of a Controlling Interest in Bollinger Motors
McDermott Will & Emery represented Mullen Automotive, Inc. in the transaction. Mullen Automotive, Inc. (NASDAQ: MULN), an emerging electric vehicle (EV) manufacturer, announced its acquisition of a...
Portage Biotech’s Acquisition of Tarus Therapeutics
McDermott Will and Emery represented Portage Biotech Inc. in the transaction. Portage Biotech Inc., a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase...
Pasithea Therapeutics’ Acquisition of Alpha-5 Integrin
McDermott Will & Emery represented Pasithea Therapeutics Corp. in the transaction. Pasithea Therapeutics Corp. (Pasithea), a US biotechnology company focused on the research and discovery of...
Merck KGaA’s Out-Licensing Agreement for Osteoarthritis Asset Sprifermin
McDermott Will & Emery represented Merck KGaA on the deal. Merck KGaA, Darmstadt, Germany, a leading science and technology company, through its subsidiary Ares Trading S.A.,...
DUET Acquisition Corp.’s $86.25 Million Initial Public Offering
Nelson Mullins Riley & Scarborough LLP acted as legal counsel to DUET. McDermott Will & Emery represented EF Hutton, division of Benchmark Investments, LLC, which acted...
Nuvei Corporation’s $805 Million Initial Public Offering
Davis Polk and Fasken advised Nuvei Corporation in the offering. McCarthy Tétrault advised the syndicate of underwriters. Nuvei Corporation executed its initial public offering of 30,961,539...